Stemcentrx clinical trials
Acquired by AbbVie, Jun 1, 2016 · source ↗
The registry lists 4 studies whose lead sponsor is Stemcentrx. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jan 4, 2019.
Before and after it joined AbbVie
- First submitted before Stemcentrx became part of AbbVie
- 3
- First submitted after Stemcentrx became part of AbbVie
- 1
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Stemcentrx4 studies
Something wrong with this grouping? Tell us on the AbbVie page.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. All AbbVie studies →
- Study of SC-003 Alone and in Combination With ABBV-181 in Subjects With Platinum-Resistant/Refractory Ovarian CancerTerminatedNCT02539719Phase 1
Sponsor listed in the registry: Stemcentrx · First submitted before Stemcentrx became part of AbbVie
- SC-002 in Small Cell Lung Cancer and Large Cell Neuroendocrine CarcinomaTerminatedNCT02500914Phase 1
Sponsor listed in the registry: Stemcentrx · First submitted before Stemcentrx became part of AbbVie
- A Study of Rovalpituzumab Tesirine to Study Cardiac Ventricular Repolarization in Subjects With Small Cell Lung CancerCompletedNCT02874664Phase 1
Sponsor listed in the registry: Stemcentrx · First submitted after Stemcentrx became part of AbbVie
- Rovalpituzumab Tesirine (SC16LD6.5) in Recurrent Small Cell Lung CancerCompletedNCT01901653Phase 1/2
Sponsor listed in the registry: Stemcentrx · First submitted before Stemcentrx became part of AbbVie